Yaping Xu

1.7k total citations · 1 hit paper
61 papers, 1.2k citations indexed

About

Yaping Xu is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Yaping Xu has authored 61 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 25 papers in Cancer Research and 13 papers in Oncology. Recurrent topics in Yaping Xu's work include Cancer Genomics and Diagnostics (15 papers), Pancreatic and Hepatic Oncology Research (6 papers) and Genetic factors in colorectal cancer (6 papers). Yaping Xu is often cited by papers focused on Cancer Genomics and Diagnostics (15 papers), Pancreatic and Hepatic Oncology Research (6 papers) and Genetic factors in colorectal cancer (6 papers). Yaping Xu collaborates with scholars based in China, United States and Ethiopia. Yaping Xu's co-authors include Yanfang Guan, Lianpeng Chang, Xuefeng Xia, Lifeng Li, Yan Gong, Meng Zhang, Shuqin Jia, Yu Yao, Yongliang Zhang and Kai Zhang and has published in prestigious journals such as Nature Communications, PLoS ONE and Journal of Hazardous Materials.

In The Last Decade

Yaping Xu

61 papers receiving 1.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Pan-cancer circulating tumor DNA detection in over 10,000 Chinese patients

2021 201 citations Yongliang Zhang, Yu Yao et al. Nature Communications profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Yaping Xu China	19	526	460	359	218	172	61	1.2k
Jinyu Li China	19	272 0.5×	742 1.6×	355 1.0×	138 0.6×	110 0.6×	50	1.5k
Zifeng Wang China	24	486 0.9×	1.0k 2.2×	262 0.7×	174 0.8×	72 0.4×	80	1.6k
Hui‐Ju Wang China	21	476 0.9×	817 1.8×	289 0.8×	184 0.8×	66 0.4×	82	1.4k
Tingting Ma China	22	515 1.0×	601 1.3×	228 0.6×	117 0.5×	126 0.7×	67	1.2k
Jie Mei China	26	646 1.2×	1.0k 2.3×	403 1.1×	393 1.8×	70 0.4×	127	2.0k
Shiyan Wang China	20	633 1.2×	1.4k 3.0×	240 0.7×	107 0.5×	93 0.5×	42	1.8k
Jieun Song South Korea	23	626 1.2×	996 2.2×	499 1.4×	125 0.6×	78 0.5×	60	2.2k
Andrea Casazza Italy	16	439 0.8×	996 2.2×	522 1.5×	165 0.8×	43 0.3×	27	2.2k
Hyun Jung Kang South Korea	18	206 0.4×	515 1.1×	371 1.0×	83 0.4×	77 0.4×	37	1.1k
Kai Huang China	24	892 1.7×	1.4k 3.1×	240 0.7×	259 1.2×	84 0.5×	92	2.1k

Countries citing papers authored by Yaping Xu

Since Specialization

Citations

This map shows the geographic impact of Yaping Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yaping Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yaping Xu more than expected).

Fields of papers citing papers by Yaping Xu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yaping Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yaping Xu. The network helps show where Yaping Xu may publish in the future.

Co-authorship network of co-authors of Yaping Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Yaping Xu. A scholar is included among the top collaborators of Yaping Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yaping Xu. Yaping Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Du, Wei, Xiaowei Wu, Qingfeng Li, et al.. (2025). Integrated bioinformatics and experimental analysis of CHAF1B as a novel biomarker and immunotherapy target in LUAD. Discover Oncology. 16(1). 43–43. 2 indexed citations

Zheng, Shengyang, Zilong Yuan, Haitao Zhao, et al.. (2025). Effective Combination of MOF and MoS2 Layers: A Novel Composite Material Capable of Rapidly Degrading Dyes. Water. 17(7). 980–980. 3 indexed citations

Wei, Jun, Yuqin Zhang, Yaping Xu, et al.. (2024). MsLBD41-like bridges auxin response factors MsARF5 and MsF3’H function to regulate low nitrogen-induced anthocyanin accumulation in Malus spectabilis leaves. Industrial Crops and Products. 214. 118572–118572. 2 indexed citations

Xie, Yi, Bo Chen, Qiong Wang, et al.. (2023). Astrocyte‐Derived Exosomes Contribute to Pathologies of Neuromyelitis Optica Spectrum Disorder in Rodent Model. Annals of Neurology. 94(1). 163–181. 17 indexed citations

Liu, Wenjing, Ye Li, Yajun Wang, et al.. (2022). DFT insights into the degradation mechanism of carbendazim by hydroxyl radicals in aqueous solution. Journal of Hazardous Materials. 431. 128577–128577. 48 indexed citations

Shi, Jie, Zhiyu Wang, Junping Zhang, et al.. (2021). Genomic Landscape and Tumor Mutational Burden Determination of Circulating Tumor DNA in Over 5,000 Chinese Patients with Lung Cancer. Clinical Cancer Research. 27(22). 6184–6196. 9 indexed citations

Dai, Chunhua, et al.. (2021). Four plasma miRNAs act as biomarkers for diagnosis and prognosis of non‑small cell lung cancer. Oncology Letters. 22(5). 792–792. 20 indexed citations

Jiang, Jiahong, Yaping Xu, Lianpeng Chang, et al.. (2021). Genomic Landscape in Neoplasm-Like Stroma Reveals Distinct Prognostic Subtypes of Pancreatic Ductal Adenocarcinoma. Frontiers in Oncology. 11. 771247–771247. 1 indexed citations

Han, Songyan, Jing Wang, Yanrong Guo, et al.. (2021). Identifying Genomic Alterations in Small Cell Lung Cancer Using the Liquid Biopsy of Bronchial Washing Fluid. Frontiers in Oncology. 11. 647216–647216. 6 indexed citations

10.

Zhang, Yongliang, Yu Yao, Yaping Xu, et al.. (2021). Pan-cancer circulating tumor DNA detection in over 10,000 Chinese patients. Nature Communications. 12(1). 11–11. 201 indexed citations breakdown →

11.

Jiang, Hongxin, et al.. (2021). Self-paired dumbbell DNA -assisted simple preparation of stable circular DNAzyme and its application in Pb2+ sensor. Analytica Chimica Acta. 1175. 338733–338733. 11 indexed citations

12.

Yang, Hongwu, et al.. (2021). Deep Neural Networks for Depression Recognition Based on 2D and 3D Facial Expressions Under Emotional Stimulus Tasks. Frontiers in Neuroscience. 15. 609760–609760. 46 indexed citations

13.

Xu, Yaping, et al.. (2021). Exosomes derived from astrocytes after oxygen-glucose deprivation promote differentiation and migration of oligodendrocyte precursor cells in vitro. Molecular Biology Reports. 48(7). 5473–5484. 15 indexed citations

14.

Rong, Guohua, Zongbi Yi, Fei Ma, et al.. (2021). DNA damage response as a prognostic indicator in metastatic breast cancer via mutational analysis. Annals of Translational Medicine. 9(3). 220–220. 13 indexed citations

15.

Ye, Song, Xiaoge Hu, Chao Ni, et al.. (2020). KLF4 p.A472D Mutation Contributes to Acquired Resistance to Cetuximab in Colorectal Cancer. Molecular Cancer Therapeutics. 19(3). 956–965. 8 indexed citations

16.

Zhou, Jiaolin, Changxi Wang, Guole Lin, et al.. (2020). Serial Circulating Tumor DNA in Predicting and Monitoring the Effect of Neoadjuvant Chemoradiotherapy in Patients with Rectal Cancer: A Prospective Multicenter Study. Clinical Cancer Research. 27(1). 301–310. 96 indexed citations

17.

Liu, Honglin, Hongting Tang, Hanlin Yang, et al.. (2020). Oct4 Regulates the Transition of Cancer Stem-Like Cells to Tumor Endothelial-Like Cells in Human Liver Cancer. Frontiers in Cell and Developmental Biology. 8. 563316–563316. 21 indexed citations

18.

Chen, Yu, Yingying Huang, Xuan Gao, et al.. (2020). CCND1 Amplification Contributes to Immunosuppression and Is Associated With a Poor Prognosis to Immune Checkpoint Inhibitors in Solid Tumors. Frontiers in Immunology. 11. 1620–1620. 49 indexed citations

19.

Zheng, Xiasheng, Hui Xu, Ruoting Zhan, et al.. (2017). Transcriptomic Comparison Reveals Candidate Genes for Triterpenoid Biosynthesis in Two Closely Related Ilex Species. Frontiers in Plant Science. 8. 634–634. 13 indexed citations

20.

Xu, Yaping, et al.. (2007). Determination of lymph node micrometastases in patients with supraglottic carcinoma. Acta Oto-Laryngologica. 127(11). 1188–1195. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact